Syra Health Corp (SYRA)

New Form 8-K - Syra Health Corp Filed: 2025-08-12 AccNo: 0001641172-25-023118 Size: 431 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Acumen Pharmaceuticals Inc (ABOS)

New Form 8-K - Acumen Pharmaceuticals, Inc. Filed: 2025-08-12 AccNo: 0001576885-25-000091 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Atossa Therapeutics Inc. (ATOS)

New Form 8-K - ATOSSA THERAPEUTICS, INC. Filed: 2025-08-12 AccNo: 0000950170-25-106944 Size: 544 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

X4 Pharmaceuticals Inc. (XFOR)

New Form 8-K - X4 Pharmaceuticals, Inc Filed: 2025-08-12 AccNo: 0001628280-25-039770 Size: 917 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item …